AI-generated summary
The authors describe a combined treatment called frequency-modulated magnetolaser therapy in 121 patients with acute ischemic stroke, compared against 30 control patients who received conventional drug treatment. The authors report that the comparison led them to recommend this therapy for ischemic stroke, especially within the so-called therapeutic window. The abstract provides limited detail on methods and outcomes.
- Who or what was studied
- Patients with acute ischemic stroke: 121 treated with combined frequency-modulated magnetolaser therapy and 30 controls receiving conventional drug treatment.
- Limits stated in the abstract
- The abstract gives little detail on outcome measures, randomization, or statistics, and the recommendation rests on a comparison with a small control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Stroke, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.